US Neurology and Immunology Asset/Indication Lead
Sanofi
August 17, 2026
Remote friendly (Cambridge, MA)
United States
$148,500 - $214,500 USD yearly
Marketing
Main Responsibilities:
- Support tactical execution of US HEVA work for Neurology (Multiple Sclerosis; Chronic Inflammatory Demyelinating Polyneuropathy) and Next-Generation Immunology assets (Atopic Dermatitis; Celiac Disease; Inflammatory Bowel Disease; IgG4-related diseases; Nasal Polyps; etc.).
Primary responsibilities:
- Design and execute HEOR research (economic modeling, database analysis, observational research, systematic literature review, evidence synthesis, post hoc clinical trial analysis, AMCP dossier development, and other HEOR deliverables) to demonstrate value and differentiation in the US market.
- Drive measurable business impact supporting commercial objectives and market access goals.
- Execute comprehensive US HEVA tactics, ensuring alignment with portfolio objectives.
- Partner with US Medical Affairs/Value & Access to ensure appropriate use of HEOR evidence in field communications and training.
- Collaborate with Value & Access, US Medical Affairs, and Policy to inform value frameworks and responses (e.g., PDAB, ICER), and value-based contracting strategies.
- Set evidence-generation priorities and translate value propositions into evidence hypotheses, requirements, and generation plans.
Internal partnerships/engagement:
- Build relationships across commercial, medical affairs, clinical development, and market access.
- Communicate health economics concepts to cross-functional stakeholders and senior leadership.
- Contribute to clinical development differentiation and US launch readiness planning.
Regulatory & compliance knowledge:
- Apply knowledge of global/US HTA processes; HTA submission experience strongly preferred.
- Ensure HEOR activities comply with internal SOPs and external laws/regulations.
- Stay current with US payer policies, formulary management, and outcomes-based contracting.
Digital & AI proficiency (nice to have):
- Use HEOR digital tools/data platforms; leverage AI-enabled solutions; understand real-world data analytics.
Stakeholder engagement/external partnerships:
- Represent the company at major scientific conferences; lead abstract development/presentation.
- Manage the US HEVA budget for the portfolios.
Qualifications:
- 3+ years in HEOR/real-world evidence (or related pharma/biotech field) OR 5+ years in a CRO/non-clinical research setting.
- Advanced degree (PhD, MD, MS, MPH, or PharmD) in a scientific discipline.
- Preferred: Experience in Neurology and/or Immunology; ICER review experience.
- Skills: Strong verbal/written communication and presentation skills; peer-reviewed publications; ability to partner cross-functionally; entrepreneurial problem-solving.
- Language: Fluent English (written and oral).
- Support tactical execution of US HEVA work for Neurology (Multiple Sclerosis; Chronic Inflammatory Demyelinating Polyneuropathy) and Next-Generation Immunology assets (Atopic Dermatitis; Celiac Disease; Inflammatory Bowel Disease; IgG4-related diseases; Nasal Polyps; etc.).
Primary responsibilities:
- Design and execute HEOR research (economic modeling, database analysis, observational research, systematic literature review, evidence synthesis, post hoc clinical trial analysis, AMCP dossier development, and other HEOR deliverables) to demonstrate value and differentiation in the US market.
- Drive measurable business impact supporting commercial objectives and market access goals.
- Execute comprehensive US HEVA tactics, ensuring alignment with portfolio objectives.
- Partner with US Medical Affairs/Value & Access to ensure appropriate use of HEOR evidence in field communications and training.
- Collaborate with Value & Access, US Medical Affairs, and Policy to inform value frameworks and responses (e.g., PDAB, ICER), and value-based contracting strategies.
- Set evidence-generation priorities and translate value propositions into evidence hypotheses, requirements, and generation plans.
Internal partnerships/engagement:
- Build relationships across commercial, medical affairs, clinical development, and market access.
- Communicate health economics concepts to cross-functional stakeholders and senior leadership.
- Contribute to clinical development differentiation and US launch readiness planning.
Regulatory & compliance knowledge:
- Apply knowledge of global/US HTA processes; HTA submission experience strongly preferred.
- Ensure HEOR activities comply with internal SOPs and external laws/regulations.
- Stay current with US payer policies, formulary management, and outcomes-based contracting.
Digital & AI proficiency (nice to have):
- Use HEOR digital tools/data platforms; leverage AI-enabled solutions; understand real-world data analytics.
Stakeholder engagement/external partnerships:
- Represent the company at major scientific conferences; lead abstract development/presentation.
- Manage the US HEVA budget for the portfolios.
Qualifications:
- 3+ years in HEOR/real-world evidence (or related pharma/biotech field) OR 5+ years in a CRO/non-clinical research setting.
- Advanced degree (PhD, MD, MS, MPH, or PharmD) in a scientific discipline.
- Preferred: Experience in Neurology and/or Immunology; ICER review experience.
- Skills: Strong verbal/written communication and presentation skills; peer-reviewed publications; ability to partner cross-functionally; entrepreneurial problem-solving.
- Language: Fluent English (written and oral).